These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2869539)

  • 1. Neuroendocrine effects of clonidine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology.
    Müller-Spahn F; Ackenheil M; Albus M; Botschev C; Naber D; Welter D
    Psychopharmacology (Berl); 1986; 88(2):190-5. PubMed ID: 2869539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.
    Müller-Spahn F; Ackenheil M; Albus M; May G; Naber D; Welter D; Zander K
    Psychopharmacology (Berl); 1984; 84(3):436-40. PubMed ID: 6151210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine-induced growth hormone secretion in chronic schizophrenia.
    Lal S; Nair NP; Thavundayil JX; Monks RC; Guyda H
    Acta Psychiatr Scand; 1983 Aug; 68(2):82-8. PubMed ID: 6137940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
    Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M
    Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine.
    Spivak B; Roitman S; Vered Y; Mester R; Graff E; Talmon Y; Guy N; Gonen N; Weizman A
    Clin Neuropharmacol; 1998; 21(4):245-50. PubMed ID: 9704166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
    Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
    Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion.
    Topper E; Gertner J; Amiel S; Press M; Genel M; Tamborlane WV
    Pediatr Res; 1985 Jun; 19(6):534-6. PubMed ID: 2989759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premenstrual failure of alpha-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine.
    Facchinetti F; Martignoni E; Nappi G; Fioroni L; Sances G; Genazzani AR
    Psychosom Med; 1989; 51(5):550-8. PubMed ID: 2552488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls.
    Sternberg DE; Charney DS; Heninger GR; Leckman JF; Hafstad KM; Landis DH
    Arch Gen Psychiatry; 1982 Mar; 39(3):285-9. PubMed ID: 6279049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: relations to psychopathology and extrapyramidal symptoms.
    Naber D; Finkbeiner C; Fischer B; Zander KJ; Ackenheil M
    Neuropsychobiology; 1980; 6(4):181-9. PubMed ID: 6104798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for alterations in alpha2-adrenergic receptor sensitivity in rats exposed to repeated cocaine administration.
    Baumann MH; Milchanowski AB; Rothman RB
    Neuroscience; 2004; 125(3):683-90. PubMed ID: 15099682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
    De Gennaro Colonna V; Zoli M; Settembrini BP; Ciceri S; De Marco A; Cella SG; Agnati LF; Muller EE
    J Pharmacol Exp Ther; 1996 Feb; 276(2):795-800. PubMed ID: 8632352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the sensitivity of the central alpha- and beta-adrenergic systems during desmethylimipramine treatment as assessed by plasma growth hormone response in the baboon.
    McWilliam JR; Meldrum BS; Checkley SA
    Psychopharmacology (Berl); 1983; 80(3):263-6. PubMed ID: 6310666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.
    van Kammen DP
    Psychol Med; 1991 Nov; 21(4):881-95. PubMed ID: 1685791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal.
    Zander KJ; Fischer B; Zimmer R; Ackenheil M
    Psychopharmacology (Berl); 1981; 73(1):43-7. PubMed ID: 6112769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
    Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
    Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.